Maze Therapeutics, Inc. Common Stock (MAZE) — Free Cash Flow Generation Index
Maze Therapeutics, Inc. Common Stock (MAZE) has a Free Cash Flow Generation Index of 1.00x as of June 2024. Free cash flow of $144.89 Million represents 1% of operating cash flow ($145.05 Million). See Maze Therapeutics, Inc. Common Stock short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Maze Therapeutics, Inc. Common Stock Free Cash Flow Generation Index (2024–2024)
Historical FCF Generation Index trend for Maze Therapeutics, Inc. Common Stock across 1 annual periods. Explore Maze Therapeutics, Inc. Common Stock (MAZE) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Maze Therapeutics, Inc. Common Stock (2024–2024)
Year-by-year Free Cash Flow Generation Index for Maze Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see Maze Therapeutics, Inc. Common Stock market cap and net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.98x | $74.81 Million | $75.95 Million | $1.15 Million | — |